Ideaya Biosciences, Inc. progresses trials for uveal melanoma and solid tumors, with key upcoming data milestones. Click for ...

In a new study published in Nature, researchers at the University of Chicago Medicine Comprehensive Cancer Center explore a ...

A rogue protein just yanked the plug on cancer’s energy grid. And researchers at the Duke University School of Medicine just ...

Learn the early warning signs of esophageal cancer that are often missed. Discover risk factors, treatment options and how to ...

Discover "Bevacizumab - Biosimilar Insight, 2025," which analyzes 25+ companies and 30+ drugs in the bevacizumab biosimilars landscape. The report covers marketed drugs, pipeline molecules, and ...

UNLOXCYT (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma Special meeting of stockholders to vote on Merge ...

Discover the connections between dental cavities, oral health, and cancer risk, including inflammation pathways, immune ...

As of March 31, 2025, LAVA had cash, cash equivalents, and short-term investments of $66.6 million, compared to cash, cash equivalents, and short-term investments of $76.6 million as of December 31, ...

The early months of 2025 have seen a surge of research centered on cannabidiol (CBD), with studies investigating its role in ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

MONTEVIDEO, Uruguay (AP) — Former Uruguayan President José Mujica, a onetime Marxist guerilla and flower farmer whose radical ...

A series of preclinical studies show that a new compound, SHP1705, targets circadian clock proteins hijacked by glioblastoma ...